Skip to main content
. 2021 Aug 19;54(5):1097–1104. doi: 10.1007/s11255-021-02972-x

Table 2.

Hospital admission symptom and signs in COVID-19 patients with and without acute kidney injury (AKI)

Total (n = 770) AKI (–) (n = 678) AKI (+) (n = 92) p value
Symptoms, n (%)
Fever 530 (69.2) 479 (71.1) 51 (55.4) 0.002a
Coughing 585 (76.4) 519 (77) 66 (71.7) 0.265a
Sputum 36 (4.7) 33 (4.9) 3 (3.3) 0.608b
Dyspnea 330 (43.1) 267 (39.6) 63 (68.5) < 0.001a
Fatigue or myalgia 606 (80.1) 535 (80.5) 71 (77.2) 0.552c
Nausea 124 (16.8) 109 (16.6) 15 (18.1) 0.863c
Diarrhea 98 (13.3) 90 (13.7) 8 (9.6) 0.387c
Anosmia 53 (7.2) 51 (7.8) 2 (2.4) 0.118c
Medications, n (%)
Angiotensin-converting-enzyme inhibitors and/or Angiotensin II receptor blocker, n (%) 192 (25.3) 162 (24.2) 30 (33) 0.071b
History of risks, n (%)
Travel history 10 (1.3) 9 (1.4) 1 (1.1) 1.005b
Contact history 243 (32.8) 221 (33.9) 22 (24.7) 0.106c
Smoking 94 (12.2) 83 (12.7) 11 (12.2) 1.004c
Alcohol 12 (1.6) 11 (1.7) 1 (1.1) 1.005b

p values in bold indicate statistical significance

aChi-square

bFisher’s exact test

cYates contiunity correction